RightFit
RecruitingNot applicable

Dry Needling in Multiple Sclerosis

The Effectiveness of Dry Needling on Reducing Spasticity and Promoting Mobility and Balance in People With Multiple Sclerosis

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years to 64 Years
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

The investigators are doing this study to see if a treatment called dry needling improves muscle spasticity (muscle tightness) in people who have Multiple Sclerosis. Dry needling involves using tiny needles, like those in acupuncture, to target some muscles, like calf muscles. It differs from traditional acupuncture as it focuses on treating or managing muscle spots, aiming to reduce muscle stiffness and pain. Dry needling may offer a minimally-invasive and medication-free approach to improve muscle spasticity. The investigators hope to see if dry needling also helps enhance balance and walking abilities. This might provide potential improvements inoverall mobility and balance.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Official eligibility criteria

Inclusion Criteria: * Age 18 to 64 years * Clinical diagnosis of Multiple Sclerosis based on the McDonald Criteria * Spasticity in their lower legs * Patient Determined Disease Steps (PDDS) score of 5 or below Exclusion Criteria: * Inability to communicate effectively with study personnel * Needle phobia * Severe varicose veins * Presence of an active implanted device * Pregnancy * Any active cancer or history within 1 year * known or suspected infection at the site of needling or in the surrounding area * Presence of a fixed plantarflexion contracture at the ankle * Acute fracture of dislocation in the region (bilateral lower extremity) * Deep vein thrombosis or peripheral vascular disease * Thrombophlebitis, or active osteomyelitis in the region (bilateral lower extremity) * Any medication changes, including antispastic medicines, for the past three months.

Study sites (1)

KS